Mesenchymal stem/stromal cells protect against autoimmunity via CCL2-dependent recruitment of myeloid-derived suppressor cells

Journal of Immunology

Volumn 194, Issue 8, 2015, Pages 3634-3645

  Lee, Hyun Ju ^a,b   Ko, Jung Hwa ^a,b   Jeong, Hyun Jeong ^a,b   Ko, Ah Young ^a,b   Kim, Mee Kum ^a,b   Wee, Won Ryang ^a,b   Yoon, Sun Ok ^c   Oh, Joo Youn ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN; CCL2 PROTEIN, MOUSE; HLA ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE UVEITIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHATIC DRAINAGE; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; TH1 CELL; TH17 CELL; TIME; ANIMAL; BONE MARROW CELL; CELL CULTURE; GENETICS; IMMUNOLOGY; INFLAMMATION; LYMPH NODE; PHYSIOLOGY;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CCL2; FEMALE; GENE KNOCKDOWN TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFLAMMATION; LYMPH NODES; MESENCHYMAL STROMAL CELLS; MICE; MYELOID CELLS; TH1 CELLS; TH17 CELLS;

EID: 84927674494     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402139     Document Type: Article

References (62)

1. Uccelli, A., L. Moretta, and V. Pistoia. 2008. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8:726-736.
2. Le Blanc, K., and D. Mougiakakos. 2012. Multipotent mesenchymal stromal cells and the innate immune system. Nat. Rev. Immunol. 12:383-396.
3. Uccelli, A., and D. J. Prockop. 2010. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr. Opin. Immunol. 22:768-774.
4. Lee, R. H., A. A. Pulin, M. J. Seo, D. J. Kota, J. Ylostalo, B. L. Larson, L. Semprun-Prieto, P. Delafontaine, and D. J. Prockop. 2009. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63.
5. Dazzi, F., L. Lopes, and L. Weng. 2012. Mesenchymal stromal cells: a key player in "innate tolerance"? Immunology 137:206-213.
6. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90:516-525.
7. Di Ianni, M., B. Del Papa, M. De Ioanni, L. Moretti, E. Bonifacio, D. Cecchini, P. Sportoletti, F. Falzetti, and A. Tabilio. 2008. Mesenchymal cells recruit and regulate T regulatory cells. Exp. Hematol. 36:309-318.
8. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162-174.
9. Greten, T. F., M. P. Manns, and F. Korangy. 2011. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11:802-807.
10. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12:253-268.
11. Almand, B., J. I. Clark, E. Nikitina, J. Van Beynen, N. R. English, S. C. Knight, D. P. Carbone, and D. I. Gabrilovich. 2001. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166:678-689.
12. Ostrand-Rosenberg, S. 2010. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity. Cancer Immunol. Immunother. 59:1593-1600.
13. Mundy-Bosse, B. L., G. B. Lesinski, A. C. Jaime-Ramirez, K. Benninger, M. Khan, P. Kuppusamy, K. Guenterberg, S. V. Kondadasula, A. R. Chaudhury, K. M. La Perle, et al. 2011. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res. 71:5101-5110.
14. Cripps, J. G., and J. D. Gorham. 2011. MDSC in autoimmunity. Int. Immunopharmacol. 11:789-793.
15. +Ly-6Chi suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179:5228-5237.
16. Zhu, B., J. K. Kennedy, Y. Wang, C. Sandoval-Garcia, L. Cao, S. Xiao, C. Wu, W. Elyaman, and S. J. Khoury. 2011. Plasticity of Ly-6Chi myeloid cells in T cell regulation. J. Immunol. 187:2418-2432.
17. Bowen, J. L., and J. K. Olson. 2009. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease. J. Immunol. 183:6971-6980.
18. Haile, L. A., R. Von Wasielewski, J. Gamrekelashvili, C. Krüger, O. Bachmann, A. M. Westendorf, J. Buer, R. Liblau, M. P. Manns, F. Korangy, and T. F. Greten. 2008. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135:871-881, e1-e5.
19. Ostanin, D. V., and D. Bhattacharya. 2013. Myeloid-derived suppressor cells in the inflammatory bowel diseases. Inflamm. Bowel Dis. 19:2468-2477.
20. Kerr, E. C., B. J. Raveney, D. A. Copland, A. D. Dick, and L. B. Nicholson. 2008. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J. Autoimmun. 31:354-361.
21. Fujii, W., E. Ashihara, H. Hirai, H. Nagahara, N. Kajitani, K. Fujioka, K. Murakami, T. Seno, A. Yamamoto, H. Ishino, et al. 2013. Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J. Immunol. 191:1073-1081.
22. Yin, B., G. Ma, C. Y. Yen, Z. Zhou, G. X. Wang, C. M. Divino, S. Casares, S. H. Chen, W. C. Yang, and P. Y. Pan. 2010. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J. Immunol. 185:5828-5834.
23. Caspi, R. R. 2003. Experimental autoimmune uveoretinitis in the rat and mouse. Curr. Protoc. Immunol. Chapter 15:6.
24. Peister, A., J. A. Mellad, B. L. Larson, B. M. Hall, L. F. Gibson, and D. J. Prockop. 2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668.
25. Agarwal, R. K., P. B. Silver, and R. R. Caspi. 2012. Rodent models of experimental autoimmune uveitis. Methods Mol. Biol. 900:443-469.
26. Saiwai, H., H. Kumamaru, Y. Ohkawa, K. Kubota, K. Kobayakawa, H. Yamada, T. Yokomizo, Y. Iwamoto, and S. Okada. 2013. Ly6C+Ly6G2 myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury. J. Neurochem. 125:74-88.
27. +CD11b+ population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463-1474.
28. Kim, J. V., S. S. Kang, M. L. Dustin, and D. B. McGavern. 2009. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457:191-195.
29. Norris, B. A., L. S. Uebelhoer, H. I. Nakaya, A. A. Price, A. Grakoui, and B. Pulendran. 2013. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38:309-321.
30. Sade-Feldman, M., J. Kanterman, E. Ish-Shalom, M. Elnekave, E. Horwitz, and M. Baniyash. 2013. Tumor necrosis factor-a blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38:541-554.
31. Caspi, R. 2008. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol. Res. 42:41-50.
32. Caspi, R. R. 2010. A look at autoimmunity and inflammation in the eye. J. Clin. Invest. 120:3073-3083.
33. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275-283.
34. H17 and regulatory T cells. Nature 441:235-238.
35. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFb in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
36. Gee, K., C. Guzzo, N. F. Che Mat, W. Ma, and A. Kumar. 2009. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm. Allergy Drug Targets 8:40-52.
37. H17 cell differentiation. Immunity 38:336-348.
38. Youn, J. I., and D. I. Gabrilovich. 2010. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40:2969-2975.
39. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloidderived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791-5802.
40. Movahedi, K., M. Guilliams, J. Van Den Bossche, R. Van Den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111:4233-4244.
41. Greifenberg, V., E. Ribechini, S. Rössner, and M. B. Lutz. 2009. Myeloidderived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development. Eur. J. Immunol. 39:2865-2876.
42. Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5:641-654.
43. Rodríguez, P. C., and A. C. Ochoa. 2008. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 222:180-191.
44. Sinha, P., V. K. Clements, A. M. Fulton, and S. Ostrand-Rosenberg. 2007. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 67:4507-4513.
45. Serafini, P., R. Carbley, K. A. Noonan, G. Tan, V. Bronte, and I. Borrello. 2004. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64:6337-6343.
46. Sawanobori, Y., S. Ueha, M. Kurachi, T. Shimaoka, J. E. Talmadge, J. Abe, Y. Shono, M. Kitabatake, K. Kakimi, N. Mukaida, and K. Matsushima. 2008. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111:5457-5466.
47. 2+ myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 72:876-886.
48. Qian, B. Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L. R. Campion, E. A. Kaiser, L. A. Snyder, and J. W. Pollard. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475:222-225.
49. Ren, G., X. Zhao, Y. Wang, X. Zhang, X. Chen, C. Xu, Z. R. Yuan, A. I. Roberts, L. Zhang, B. Zheng, et al. 2012. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFa. Cell Stem Cell 11:812-824.
50. Rafei, M., J. Hsieh, S. Fortier, M. Li, S. Yuan, E. Birman, K. Forner, M. N. Boivin, K. Doody, M. Tremblay, et al. 2008. Mesenchymal stromal cellderived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood 112:4991-4998.
51. H17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol. 182:5994-6002.
52. Young, M. R., M. Newby, and H. T. Wepsic. 1987. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47:100-105.
53. Buessow, S. C., R. D. Paul, and D. M. Lopez. 1984. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice. J. Natl. Cancer Inst. 73:249-255.
54. Dugast, A. S., T. Haudebourg, F. Coulon, M. Heslan, F. Haspot, N. Poirier, R. Vuillefroy De Silly, C. Usal, H. Smit, B. Martinet, et al. 2008. Myeloidderived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol. 180:7898-7906.
55. Garcia, M. R., L. Ledgerwood, Y. Yang, J. Xu, G. Lal, B. Burrell, G. Ma, D. Hashimoto, Y. Li, P. Boros, et al. 2010. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J. Clin. Invest. 120:2486-2496.
56. Youn, J. I., M. Collazo, I. N. Shalova, S. K. Biswas, and D. I. Gabrilovich. 2012. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91:167-181.
57. Zhu, J., X. Huang, and Y. Yang. 2012. Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer. J. Virol. 86:13689-13696.
58. De Palma, M., and C. E. Lewis. 2013. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23:277-286.
59. Izhak, L., G. Wildbaum, S. Jung, A. Stein, Y. Shaked, and N. Karin. 2012. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis. PLoS ONE 7:e28305.
60. Knight, D. A., S. F. Ngiow, M. Li, T. Parmenter, S. Mok, A. Cass, N. M. Haynes, K. Kinross, H. Yagita, R. C. Koya, et al. 2013. Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. J. Clin. Invest. 123:1371-1381.
61. Bianco, P., X. Cao, P. S. Frenette, J. J. Mao, P. G. Robey, P. J. Simmons, and C. Y. Wang. 2013. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19:35-42.
62. Zhang, X., X. Ren, G. Li, C. Jiao, L. Zhang, S. Zhao, J. Wang, Z. C. Han, and X. Li. 2011. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Invest. Ophthalmol. Vis. Sci. 52:3143-3152.